Home Privacy Archive Realtime Report

Stock Trading History of Searson James E

The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Searson James E since year 2005. The trader's CIK number is 1325980. At the time of this reporting, Searson James E is the Chief Financial Officer of Drugmax Inc (stock ticker symbol DMAX).

Stock purchases, sales, and option exercises reported by *Searson James E* since 2005.
Trade Date	Symbol	Company Name (Issuer)	Trade Type	Shares	Price ($)	Value ($)
2005-09-29	DMAX	Drugmax Inc	Purchase	23,000	1.58	36,248

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Searson James E (Chief Financial Officer of Drugmax Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.